Boston Trust Walden’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
Other funds holding TECH
BCM
ACM
MPI
Boston Trust Walden's TECH Position: Q2 2019 in Review
Boston Trust Walden sold out of Bio-Techne (TECH) in Q2 2019, closing a stake of 204,840 shares — an estimated $10.2M sold.
Boston Trust Walden first reported a position in TECH in Q2 2013 and held it in 24 quarters. The position peaked at $33.8M in Q3 2013. 369 funds tracked by Wall St. Rank hold TECH as of Q2 2019.
- Boston Trust Walden reported no remaining Bio-Techne position as of Q2 2019 after selling out during the quarter.
- Boston Trust Walden sold 204,840 Bio-Techne shares in Q2 2019, an estimated $10.2M.
- Boston Trust Walden first reported a position in Bio-Techne in Q2 2013 and held it in 24 quarters.
- Boston Trust Walden's Bio-Techne position peaked at $33.8M in Q3 2013.
- 369 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2019.
Based on Boston Trust Walden's 13F filing for Q2 2019, filed 25 Jul 2019.